Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Boot

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2019
Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancerLaura S Mertens, Mark A Behrendt, Akash M Mehta, et al.
Journal of Surgical Oncology|January 11, 2021
Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trialWillem J Koemans, Rosa T van der Kaaij, Emma C E Wassenaar, et al.
JMIR Research Protocols|July 15, 2017
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE StudyRosa T van der Kaaij, Hidde Jw Braam, Henk Boot, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2018
Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acidsDaphne L van der Velden, Geert A Cirkel, Julia M Houthuijzen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2017
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based studyKoen P Rovers, Geert A Simkens, Pauline A Vissers, et al.
Gastroenterology|May 2, 2002
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationHongxiang Liu, Hongtao Ye, Agnes Ruskone-Fourmestraux, et al.
Lancet (London, England)|October 27, 2004
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trialMarjolein Y V Homs, Ewout W Steyerberg, Wilhelmina M H Eijkenboom, et al.
Investigational New Drugs|December 9, 2015
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II studyDidier Meulendijks, Laurens V Beerepoot, Henk Boot, et al.
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
Annals of Surgery|July 12, 2018
Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS TrialYvette H M Claassen, Romy M van Amelsfoort, Henk H Hartgrink, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2019
Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancerLaura S Mertens, Mark A Behrendt, Akash M Mehta, et al.
Journal of Surgical Oncology|January 11, 2021
Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trialWillem J Koemans, Rosa T van der Kaaij, Emma C E Wassenaar, et al.
JMIR Research Protocols|July 15, 2017
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE StudyRosa T van der Kaaij, Hidde Jw Braam, Henk Boot, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2018
Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acidsDaphne L van der Velden, Geert A Cirkel, Julia M Houthuijzen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2017
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based studyKoen P Rovers, Geert A Simkens, Pauline A Vissers, et al.
Gastroenterology|May 2, 2002
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationHongxiang Liu, Hongtao Ye, Agnes Ruskone-Fourmestraux, et al.
Lancet (London, England)|October 27, 2004
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trialMarjolein Y V Homs, Ewout W Steyerberg, Wilhelmina M H Eijkenboom, et al.
Investigational New Drugs|December 9, 2015
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II studyDidier Meulendijks, Laurens V Beerepoot, Henk Boot, et al.
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
Annals of Surgery|July 12, 2018
Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS TrialYvette H M Claassen, Romy M van Amelsfoort, Henk H Hartgrink, et al.
Pageof 6